NCT05698056 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Saldanha OL, Muti HS, Grabsch HI, Langer R, Dislich B, Kohlruss M, Keller G, van Treeck M, Hewitt KJ, Kolbinger FR, Veldhuizen GP, Boor P, Foersch S, Truhn D, Kather JN
Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learning. Gastric Cancer. 2023 Mar;26(2):264-274. doi: 10.1007/s10120-022-01347-0. Epub 2022 Oct 20.

A Retrospective Analysis of Magnetic Resonance Imaging Data for Breast Cancer Screening in the Open Consortium for Decentralized Medical Artificial Intelligence

Details for clinical trial NCT05698056

Clinical trial NCT05698056 - References